apomorphine has been researched along with dihydrexidine in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (66.67) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brusniak, MY; Neve, KA; Pearlman, RS; Wilcox, RE | 1 |
Brusniak, MY; DuRand, CJ; Huang, WH; Neve, KA; Pearlman, RS; Teeter, MM; Wiens, BL; Wilcox, DM; Wilcox, RE | 1 |
Bone, RG; Villar, HO | 1 |
Schechter, MD | 1 |
Lawler, CP; Mailman, RB; Nichols, DE; Smith, HP | 1 |
Geyer, MA; Lehmann-Masten, V; Ralph-Williams, RJ | 1 |
6 other study(ies) available for apomorphine and dihydrexidine
Article | Year |
---|---|
Comparative molecular field analysis-based prediction of drug affinities at recombinant D1A dopamine receptors.
Topics: Animals; Cell Line; Chlorocebus aethiops; Computer Graphics; Dopamine; Dopamine Agonists; Glioma; Humans; Kinetics; Models, Molecular; Receptors, Dopamine D1; Recombinant Proteins; Structure-Activity Relationship; Tumor Cells, Cultured | 1996 |
CoMFA-based prediction of agonist affinities at recombinant wild type versus serine to alanine point mutated D2 dopamine receptors.
Topics: Alanine; Amino Acid Substitution; Animals; Bromocriptine; Combinatorial Chemistry Techniques; Dopamine Agonists; Models, Molecular; Pergolide; Point Mutation; Radioligand Assay; Rats; Receptors, Dopamine D2; Recombinant Proteins; Serine; Structure-Activity Relationship; Tumor Cells, Cultured | 2000 |
Discriminating D1 and D2 agonists with a hydrophobic similarity index.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Apomorphine; Benzazepines; Chemical Phenomena; Chemistry, Physical; Chromans; Dopamine Agonists; Drug Design; Ergolines; Indoles; Ligands; Lisuride; Models, Molecular; Phenanthridines; Quinpirole; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1995 |
The discriminative properties of the D1 dopamine agonist dihydrexidine in the rat.
Topics: Amphetamine; Animals; Apomorphine; Benzazepines; Cocaine; Discrimination, Psychological; Dopamine Agonists; Dose-Response Relationship, Drug; Male; Phenanthridines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1 | 1995 |
Locomotor inhibition, yawning and vacuous chewing induced by a novel dopamine D2 post-synaptic receptor agonist.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Apomorphine; Benzazepines; Computer Simulation; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Idazoxan; Locomotion; Male; Mastication; Phenanthridines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Reference Standards; Remoxipride; Stereoisomerism; Yawning | 1997 |
Dopamine D1 rather than D2 receptor agonists disrupt prepulse inhibition of startle in mice.
Topics: Animals; Apomorphine; Benzazepines; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Female; Mice; Mice, Inbred C57BL; Mice, Knockout; Pergolide; Phenanthridines; Quinpirole; Raclopride; Receptors, Dopamine D1; Receptors, Dopamine D2; Reflex, Startle | 2003 |